JP2016516751A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516751A5 JP2016516751A5 JP2016506282A JP2016506282A JP2016516751A5 JP 2016516751 A5 JP2016516751 A5 JP 2016516751A5 JP 2016506282 A JP2016506282 A JP 2016506282A JP 2016506282 A JP2016506282 A JP 2016506282A JP 2016516751 A5 JP2016516751 A5 JP 2016516751A5
- Authority
- JP
- Japan
- Prior art keywords
- propolis
- composition
- weight
- cyclodextrin
- gastrointestinal cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ609074 | 2013-04-05 | ||
| NZ60907413 | 2013-04-05 | ||
| PCT/NZ2014/000060 WO2014163513A1 (en) | 2013-04-05 | 2014-04-07 | Therapeutic compositions and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016516751A JP2016516751A (ja) | 2016-06-09 |
| JP2016516751A5 true JP2016516751A5 (https=) | 2017-08-03 |
| JP6429859B2 JP6429859B2 (ja) | 2018-11-28 |
Family
ID=51658696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016506282A Active JP6429859B2 (ja) | 2013-04-05 | 2014-04-07 | 治療用組成物およびその用途 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20160051594A1 (https=) |
| EP (1) | EP2983681B1 (https=) |
| JP (1) | JP6429859B2 (https=) |
| KR (1) | KR20160021081A (https=) |
| CN (1) | CN105307665B (https=) |
| AU (1) | AU2014250139B2 (https=) |
| BR (1) | BR112015025025A2 (https=) |
| CA (1) | CA2908185A1 (https=) |
| EA (1) | EA201591925A1 (https=) |
| SG (1) | SG11201508167PA (https=) |
| TW (1) | TW201532608A (https=) |
| WO (1) | WO2014163513A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160030364A1 (en) * | 2013-04-05 | 2016-02-04 | Manuka Health New Zealand Limited | Therapeutic Compositions and Uses Thereof |
| CN105307665B (zh) * | 2013-04-05 | 2021-09-28 | 蜜纽康新西兰有限公司 | 治疗性组合物和其用途 |
| AU2015290284A1 (en) * | 2014-07-18 | 2017-01-19 | Manuka Health New Zealand Limited | Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health |
| AU2017237651A1 (en) * | 2016-03-24 | 2018-11-01 | Manuka Health New Zealand Limited | Therapeutic compositions and uses thereof |
| ITUA20163755A1 (it) * | 2016-05-24 | 2017-11-24 | Aboca Spa Societa Agricola | Composizioni a base di gemme di pioppo e loro usi |
| CN107194205B (zh) * | 2017-05-31 | 2020-11-24 | 浙江大学 | 具有杀菌活性的jak2激酶抑制剂及其虚拟筛选方法 |
| WO2019226469A1 (en) * | 2018-05-19 | 2019-11-28 | Fort Lewis College | Chemical compositions for combating honey bee pests and pathogens |
| RU2697839C1 (ru) * | 2018-11-14 | 2019-08-21 | Александр Александрович Кролевец | Способ получения нанокапсул сухого экстракта прополиса |
| JP7166965B2 (ja) * | 2019-03-13 | 2022-11-08 | 株式会社ファンケル | ｂＦＧＦ発現増強用組成物 |
| TR201908777A2 (tr) * | 2019-06-13 | 2019-07-22 | Sbs Bilimsel Bio Coezuemler Sanayi Ve Ticaret A S | Suda Çözünür ve Suda Çözünür Olmayan Özellikte Yüksek Antioksidan Kapasitesine Sahip Propolis Ürünleri ve Üretim Yöntemi |
| EP4117653A4 (en) * | 2020-03-13 | 2024-07-03 | University of New Brunswick | Composition and use of a caffeic acid phenethyl ester (cape) compound to treat cancer |
| KR102470869B1 (ko) * | 2020-12-18 | 2022-11-29 | 대한민국 | 프로테아좀 저해제 및 프로폴리스를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물 및 이의 용도 |
| CN117551222A (zh) * | 2022-08-04 | 2024-02-13 | 中科中山药物创新研究院 | 大蒜素-环糊精包合物共晶的晶型及其制备方法和应用 |
| CN116492324A (zh) * | 2023-01-04 | 2023-07-28 | 河南科技大学第一附属医院 | 咖啡酸在预防和治疗结直肠癌中的应用、含咖啡酸的药物 |
| WO2024246220A1 (en) * | 2023-05-31 | 2024-12-05 | Institut National de la Santé et de la Recherche Médicale | Methods and compositions for treating lung cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| JP3035834B2 (ja) * | 1991-04-11 | 2000-04-24 | 株式会社林原生物化学研究所 | プロポリス成分含有固状物とその製造方法並びに用途 |
| US5561116A (en) * | 1991-04-11 | 1996-10-01 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Solid product containing propolis components, and preparation and uses thereof |
| US5922324A (en) | 1995-01-31 | 1999-07-13 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Propolis extract with improved water-solubility |
| JP4135816B2 (ja) * | 1995-11-24 | 2008-08-20 | 株式会社林原生物化学研究所 | 水溶性を向上させたプロポリス抽出物 |
| CN1241577C (zh) * | 2003-03-13 | 2006-02-15 | 吉林大学 | 环糊精衍生物的药物用途及其药物组合物 |
| JP4950682B2 (ja) * | 2007-01-30 | 2012-06-13 | アピ株式会社 | プロポリス抽出物 |
| GR1007520B (el) * | 2010-12-02 | 2012-02-02 | Apivita - Καλλυντικα - Διαιτητικα - Φαρμακα Ανωνυμη Εμπορικη Και Βιοτεχνικη Εταιρεια, | Ταυτοχρονη εκχυλιση και σχηματισμος συμπλοκων εγκλεισμου των δραστικων συστατικων της προπολης με υδροξυπροπυλο-β-κυκλοδεξτρινη |
| KR20130106441A (ko) * | 2011-01-31 | 2013-09-27 | 와커 헤미 아게 | 지용성 물질을 포함하는 수용액의 제조방법 |
| US20160030364A1 (en) | 2013-04-05 | 2016-02-04 | Manuka Health New Zealand Limited | Therapeutic Compositions and Uses Thereof |
| CN105307665B (zh) * | 2013-04-05 | 2021-09-28 | 蜜纽康新西兰有限公司 | 治疗性组合物和其用途 |
-
2014
- 2014-04-07 CN CN201480030083.7A patent/CN105307665B/zh active Active
- 2014-04-07 AU AU2014250139A patent/AU2014250139B2/en active Active
- 2014-04-07 KR KR1020157030505A patent/KR20160021081A/ko not_active Withdrawn
- 2014-04-07 BR BR112015025025A patent/BR112015025025A2/pt not_active IP Right Cessation
- 2014-04-07 EA EA201591925A patent/EA201591925A1/ru unknown
- 2014-04-07 WO PCT/NZ2014/000060 patent/WO2014163513A1/en not_active Ceased
- 2014-04-07 EP EP14779790.6A patent/EP2983681B1/en active Active
- 2014-04-07 TW TW103112676A patent/TW201532608A/zh unknown
- 2014-04-07 US US14/781,863 patent/US20160051594A1/en not_active Abandoned
- 2014-04-07 JP JP2016506282A patent/JP6429859B2/ja active Active
- 2014-04-07 SG SG11201508167PA patent/SG11201508167PA/en unknown
- 2014-04-07 CA CA2908185A patent/CA2908185A1/en not_active Abandoned
-
2017
- 2017-03-21 US US15/465,414 patent/US10420804B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016516751A5 (https=) | ||
| Yang et al. | mTOR-mediated immunometabolic reprogramming nanomodulators enable sensitive switching of energy deprivation-induced microglial polarization for Alzheimer’s disease management | |
| JP2014098034A5 (https=) | ||
| JP2016515615A5 (https=) | ||
| RaviKKumar et al. | A comprehensive review on ulcer and their treatment | |
| JP2016535780A5 (https=) | ||
| TR201909355T4 (tr) | Oral uygulama için proton bağlayıcı polimerler. | |
| JP2014525454A5 (https=) | ||
| CN111989095A (zh) | 预防或治疗肿瘤疗法副作用的方法 | |
| Basu et al. | Toxicity with radiotherapy for oral cancers and its management: A practical approach | |
| JP2016521289A5 (https=) | ||
| JP2016535044A5 (https=) | ||
| MX2019005104A (es) | Composiciones de zinc-y-pga y métodos para tratar el cancer. | |
| PH12017500646B1 (en) | Treatment or prevention of anaemia in pregnant non-human mammals | |
| JP2016069317A5 (ja) | 腎不全進行抑制剤、腎不全予防剤、尿毒症治療剤、インドキシル硫酸産生阻害剤、心血管系疾患予防剤、及び食品組成物 | |
| EA201270298A1 (ru) | Способ лечения злокачественной опухоли | |
| MX2021015467A (es) | Compuestos y metodos de uso. | |
| JP2015513554A5 (https=) | ||
| Leung | Discoloration of nail beds and skin from minocycline | |
| Makedonova et al. | Studying clinical and pathomorphological changes in gingival tissues when applying platelet-rich autoplasma regenerative method | |
| El-Agamy et al. | Protective role of panax gensing on fluvoxamine maleate induced structural changes in the submandibular salivary gland of rats | |
| Li et al. | DIPG-89. Enhancement of blood-brain barrier penetration and tumor targeted drug delivery for DMG using a p-selectin targeted nanomedicine approach | |
| CN103690752B (zh) | 一种治疗正畸牙龈炎的药剂 | |
| Craig-Schwartz et al. | DIPG-87. TARGETING GENE-REPRESSIVE EPIGENETIC REGULATION TO INDUCE INTERFERON SIGNALING IN DIFFUSE MIDLINE GLIOMA | |
| EP2986277B1 (fr) | Utilisation de xénon pour limiter la migration de cellules tumorales |